OLYS Pharma
ActiveSummary
OLYS Pharma has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €578,974 and a net result of €14,126. Equity has been growing by about 33% per year since 2021. Its solvency ranks better than 59% of 75 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Official details
Source: KBO- Status
- Active since 25-09-2020 Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201and 1 other
- Establishment unit
- 2.308.807.064 4537 Verlaine, since 25-09-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 15-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.6%
- Gross margin
- €158,424
- ▼ 75.0%
- Turnover
- ≈ €400,000
- estimated
- Profit
- €14,126
- ▼ 97.4%
- Equity
- €578,974
- ▲ 2.5%
- Total assets
- €1.0m
- ▲ 0.2%
Score breakdownraises risk1 change of registered office in 24 monthsLiquidity: current ratio 0.34, cash €19,124, halvedlowers riskSize: total assets €1.0mFigures for financial year 2025 (filed on 27-07-2026)Show the evidence
Checked score
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 66% of them on solvency, 44% on liquidity, 58% on profitability and 54% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 5 accounts on average 5 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Registered office moved from Verlaine to La HulpePermanent representative: Philippe VAN WESEPOEL
- · Gazette deed Amendment of the articles · Miscellaneous
- · Gazette deed Registered office moved within Verlaine
Comparable companies
These companies have the same main activity as OLYS Pharma: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €298,000 and €1.2m, founded between 2017 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| OLYS Pharma La Hulpe | €1.0m | €0.2m |
| 272BIO Gent | €0.7m | €0.1m |
| HEW PHARMA Kalmthout | €1.0m | €0.1m |
| INTIBIO Bree | €0.4m | €0.3m |
| Dierenartsen Hond en Kat Deinze | €0.3m | €0.08m |
| BRUPHARM PHARMALAB Mons | €0.3m | €0.09m |
| Pharmentum Kontich | €1.2m | €0.04m |
Key facts about OLYS Pharma
- What is the company number of OLYS Pharma?
- The company number of OLYS Pharma is 0754.895.372. The VAT number is the same number with BE in front: BE 0754.895.372.
- Where is OLYS Pharma based?
- The registered office is at Avenue Wolfers 32, 1310 La Hulpe.Company details
- What does OLYS Pharma do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
- What is the legal form of OLYS Pharma?
- The legal form of OLYS Pharma is Private limited company (BV).
- When was OLYS Pharma founded?
- OLYS Pharma was founded on 25-09-2020.
- Is OLYS Pharma still active?
- Yes, OLYS Pharma is an active enterprise in the KBO register.
- How many employees does OLYS Pharma have?
- OLYS Pharma had an average of 0.4 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of OLYS Pharma?
- The turnover in financial year 2025 is ≈ €400,000. This figure is estimated from the gross margin of €158,424 and 2,211 comparable companies of the same size. It probably lies between €260,000 and €610,000. It is a rough estimate.
- Is OLYS Pharma profitable?
- In financial year 2025, OLYS Pharma made a profit of €14,126.
- Where can I find the annual accounts of OLYS Pharma?
- OLYS Pharma filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of OLYS Pharma due?
- OLYS Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.